Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Agner

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Cancer Reports (Hoboken, N.J.)|August 5, 2025
Population-Based Survival Analysis of Solitary Plasmacytoma of Spine in the United States From 2000 to 2020Kevin E Agner, Luke G Comisford, Alec G Kotler, et al.
Ugeskrift for Laeger|November 5, 1990
[Selective screening for hypercholesterolemia. Results from a screening model in general practice]E Agner, T E Christensen, M S Mahnfeldt, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society|July 5, 2001
Synthesis, biological activity, and solution structures of a cyclic dodecapeptide from the EGF-2 domain of blood coagulation factor VIIC K Hu, M Llinás, K E Agner, et al.
Journal of Cardiovascular Electrophysiology|July 8, 1998
Novel donor splice site mutation in the KVLQT1 gene is associated with long QT syndromeJ K Kanters, L A Larsen, M Orholm, et al.
Acta Dermato-Venereologica|July 29, 2006
Childhood oral mucous membrane pemphigoid presenting as desquamative gingivitis in a 4-year-old girlSilvia V Lourenço, Paula Boggio, Luis E Agner Machado Martins, et al.
Ugeskrift for Laeger|April 28, 1980
[Priorities in the health services and population studies in Glostrup]P F Hansen, L Hagerup, M Eriksen, et al.
The Biochemical Journal|March 1, 1993
Benzyloxycarbonyl-D-Phe-Pro-methoxypropylboroglycine: a novel inhibitor of thrombin with high selectivity containing a neutral side chain at the P1 positionG Claeson, M Philipp, E Agner, et al.
Ugeskrift for Laeger|November 5, 1990
[Screening for cardiovascular risk factors in a large workplace]E Agner, K Jacobsen, M S Mahnfeldt, et al.
Ugeskrift for Laeger|November 30, 2000
[Dofetilide to patients with heart failure and left ventricular dysfunction]C T Torp-Pedersen, M Møller, P E Bloch-Thomsen, et al.
Scandinavian Journal of Gastroenterology|January 1, 1984
Additional antacid does not increase the effect of cimetidine in gastric ulcer diseaseS J Rune, K G Jensen, H R Wulff, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Cancer Reports (Hoboken, N.J.)|August 5, 2025
Population-Based Survival Analysis of Solitary Plasmacytoma of Spine in the United States From 2000 to 2020Kevin E Agner, Luke G Comisford, Alec G Kotler, et al.
Ugeskrift for Laeger|November 5, 1990
[Selective screening for hypercholesterolemia. Results from a screening model in general practice]E Agner, T E Christensen, M S Mahnfeldt, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society|July 5, 2001
Synthesis, biological activity, and solution structures of a cyclic dodecapeptide from the EGF-2 domain of blood coagulation factor VIIC K Hu, M Llinás, K E Agner, et al.
Journal of Cardiovascular Electrophysiology|July 8, 1998
Novel donor splice site mutation in the KVLQT1 gene is associated with long QT syndromeJ K Kanters, L A Larsen, M Orholm, et al.
Acta Dermato-Venereologica|July 29, 2006
Childhood oral mucous membrane pemphigoid presenting as desquamative gingivitis in a 4-year-old girlSilvia V Lourenço, Paula Boggio, Luis E Agner Machado Martins, et al.
Ugeskrift for Laeger|April 28, 1980
[Priorities in the health services and population studies in Glostrup]P F Hansen, L Hagerup, M Eriksen, et al.
The Biochemical Journal|March 1, 1993
Benzyloxycarbonyl-D-Phe-Pro-methoxypropylboroglycine: a novel inhibitor of thrombin with high selectivity containing a neutral side chain at the P1 positionG Claeson, M Philipp, E Agner, et al.
Ugeskrift for Laeger|November 5, 1990
[Screening for cardiovascular risk factors in a large workplace]E Agner, K Jacobsen, M S Mahnfeldt, et al.
Ugeskrift for Laeger|November 30, 2000
[Dofetilide to patients with heart failure and left ventricular dysfunction]C T Torp-Pedersen, M Møller, P E Bloch-Thomsen, et al.
Scandinavian Journal of Gastroenterology|January 1, 1984
Additional antacid does not increase the effect of cimetidine in gastric ulcer diseaseS J Rune, K G Jensen, H R Wulff, et al.
Pageof 9